MacroGenics, Inc. (MGNX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.50 |
| Open | 5.50 |
| Bid | 5.52 x 100 |
| Ask | 5.55 x 300 |
| Day's range | 5.45 - 5.77 |
| 52-week range | 3.14 - 21.88 |
| Volume | |
| Avg. volume | 2,419,361 |
| Market cap | 347.616M |
| Beta (5Y monthly) | 2.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.38 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.80 |
Simply Wall St.MacroGenics Insider Ups Holding By 83% During Year
Looking at MacroGenics, Inc.'s ( NASDAQ:MGNX ) insider transactions over the last year, we can see that insiders were...
GlobeNewswireMacroGenics to Participate in Upcoming Investor Conference
ROCKVILLE, MD, June 11, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conference this month: Goldman Sachs 45th Annual Global Healthcare Conference (Miami Beach). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., P
- Simply Wall St.
Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three years ago
This month, we saw the MacroGenics, Inc. ( NASDAQ:MGNX ) up an impressive 37%. But that doesn't change the fact that...
© 2024 Yahoo. All rights reserved.